XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
BUSINESS SEGMENTS (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
SCHEDULE OF BUSINESS SEGMENT

 

  

June 30,

2024

   December 31, 2023 
         
Healthcare  $4,341   $- 
Labs and Life   2,435    408 
Corporate and other   130    317 
Total assets  $6,906   $725 

 

Summarized below is information about the Company’s operations for the three months ended June 30, 2024 and 2023 by business segment:

 

   Revenues   Losses 
   2024   2023   2024   2023 
Healthcare  $20   $-   $(67)  $- 
Labs and Life   8    12    (503)   (557)
    28    12    (570)   (557)
Impairments of intangible assets   -    -    -    (2,633)
2022 Debenture Release and PIK Note Amendment   -    -    -    (3,521)
Corporate and other (a)   -    -    (1,051)   (4,090)
Interest expense   -    -    (542)   (492)
Total  $28   $12   $(2,163)  $(11,293)

 

  (a) For the three months ended June 30, 2024, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $144 and depreciation and amortization expense of $52. For the three months ended June 30, 2023, Corporate and other includes stock-based compensation, including consulting agreement expense, of $1,268 and depreciation and amortization expense of $247.

 

Summarized below is information about the Company’s operations for the six months ended June 30, 2024 and 2023 by business segment:

 

   Revenues   Losses 
   2024   2023   2024   2023 
Healthcare  $20   $-   $(67)  $- 
Labs and Life   15    25    (870)   (1,494)
    35    25    (937)   (1,494)
Impairments of intangible assets   -    -    -    (2,633)
2022 Debenture Release and PIK Note Amendment   -    -    -    (3,521)
Corporate and other (a)   -    -    (1,887)   (10,567)
Interest expense   -    -    (843)   (717)
Total  $35   $25   $(3,667)  $(18,932)

 

(a) For the six months ended June 30, 2024, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $288 and depreciation and amortization expense of $104. For the six months ended June 30, 2023, Corporate and other includes stock-based compensation, including consulting agreement expense, of $3,894 and depreciation and amortization expense of $1,176.